Coherus Oncology Inc (CHRS)

Operating Cash Flow (Statement)

-$119.98M

Quarterly · Period ending: · USD

CHRS logo

CHRS Operating Cash Flow (Statement)

Latest reported-$119.98M
CHRS Quarterly Cash from Operations (-$7.06M → -$119.98M)
High-resolution chart · PNG

CHRS operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc Operating Cash Flow (Statement) — Quarterly (USD)
Period endingOperating Cash Flow (Statement) (USD)
-119,976,000
-57,886,000
-19,716,000
-46,339,000
-46,632,000
-25,826,000
28,608,000
-62,016,000
59,734,000
-46,766,000
-12,937,000
-54,300,000
-38,915,000
-68,732,000
-99,953,000
-37,089,000
-50,037,000
-54,045,000
-52,322,000
13,711,000
-188,000
1,367,000
33,124,000
47,353,000
60,191,000
13,477,000
17,710,000
54,951,000
12,677,000
-56,983,000
-47,363,000
-42,789,000
-35,530,000
-33,584,000
-29,922,000
-41,513,000
-55,574,000
-73,277,000
-86,892,000
-61,948,000
-27,389,000
-76,316,000
5,567,000
-59,655,000
-20,840,000
-33,062,000
-33,285,000
-5,170,000
-217,000
14,745,000
4,986,000
21,526,000
-4,032,000
-7,057,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.